S. Mazzoni

How to establish a high-risk cancer genetics clinic: Limitations and successes

M. Daly, A. Masny, B. Stearman, 2005 .

How to eastablish a high-risk cancer genetics clinic: Limitations and successes

M. Daly, A. Masny, B. Stearman, 2006, Current oncology reports.

Four-year outcomes from a prospective phase II clinical trial of moderately hypofractionated proton therapy for localized prostate cancer.

Eun Jeong Min, N. Vapiwala, H. Chao, 2019, International journal of radiation oncology, biology, physics.

Free prostate-specific antigen improves prostate cancer detection in a high-risk population of men with a normal total PSA and digitalrectal examination.

E. Horwitz, R. Uzzo, A. Pollack, 2003, Urology.

A prospective clinical trial of proton therapy for chordoma and chondrosarcoma: Feasibility assessment

John Y. K. Lee, Sean M. Grady, J. Schuster, 2019, Journal of surgical oncology.

The BaBar Physics Book: Physics at an Asymmetric B Factory

E. Vallazza, Paola Grosso, A. Khan, 1998 .

Predictors of preferences and utilities in men treated with 3D-CRT for prostate cancer.

A. Hanlon, A. Pollack, G. Hanks, 2004, International journal of radiation oncology, biology, physics.

A Novel Mouse Model of Radiation-Induced Cardiac Injury Reveals Biological and Radiological Biomarkers of Cardiac Dysfunction with Potential Clinical Relevance

S. Feigenberg, C. Koumenis, B. Ky, 2021, Clinical Cancer Research.

A Prospective Clinical Trial of Proton Therapy for Chordoma and Chondrosarcoma

M. Grady, J. Schuster, J. Dorsey, 2015 .